The Use of Immune Checkpoint Inhibitors in Oncology and the Occurrence of AKI: Where Do We Stand?
出版年份 2020 全文链接
标题
The Use of Immune Checkpoint Inhibitors in Oncology and the Occurrence of AKI: Where Do We Stand?
作者
关键词
-
出版物
Frontiers in Immunology
Volume 11, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2020-10-08
DOI
10.3389/fimmu.2020.574271
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Lactobacillus salivarius BP121 prevents cisplatin‑induced acute kidney injury by inhibition of uremic toxins such as indoxyl sulfate and p‑cresol sulfate via alleviating dysbiosis
- (2020) Tae‑Hee Lee et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Clinical Features and Outcomes of Immune Checkpoint Inhibitor–Associated AKI: A Multicenter Study
- (2020) Frank B. Cortazar et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- M2 macrophages predict worse long-term outcomes in human acute tubular necrosis
- (2020) Myung-Gyu Kim et al. Scientific Reports
- Treatment of immune checkpoint inhibitor-induced inflammatory arthritis
- (2020) Susanna Jeurling et al. CURRENT OPINION IN RHEUMATOLOGY
- Gut Bacteria Composition Drives Primary Resistance to Cancer Immunotherapy in Renal Cell Carcinoma Patients
- (2020) Lisa Derosa et al. EUROPEAN UROLOGY
- Molecular Mechanisms of Premature Aging in Hemodialysis: The Complex Interplay between Innate and Adaptive Immune Dysfunction
- (2020) Vincenzo Losappio et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
- (2020) Chaomin Wu et al. JAMA Internal Medicine
- Inflammaging and Complement System: A Link Between Acute Kidney Injury and Chronic Graft Damage
- (2020) Rossana Franzin et al. Frontiers in Immunology
- Vitiligo-like depigmentation in oncology patients treated with immunotherapies for nonmelanoma metastatic cancers
- (2019) R. C. Liu et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- Tumor mutational load predicts survival after immunotherapy across multiple cancer types
- (2019) Robert M. Samstein et al. NATURE GENETICS
- Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience
- (2019) Omar Mamlouk et al. Journal for ImmunoTherapy of Cancer
- Pre-existing malignancies in renal transplant candidates—time to reconsider waiting times
- (2019) Bruno Watschinger et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Modulating the microbiome to improve therapeutic response in cancer
- (2019) Jennifer L McQuade et al. LANCET ONCOLOGY
- mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy
- (2019) Tian Tian et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Metabolomic insights into pathophysiological mechanisms and biomarker discovery in clear cell renal cell carcinoma
- (2019) Giuseppe Lucarelli et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Programmed Cell Death 1 (PD-1) Inhibitors in Renal Transplant Patients with Advanced Cancer: A Double-Edged Sword?
- (2019) Hung-Chih Lai et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- M2 macrophages in kidney disease: biology, therapies, and perspectives
- (2019) Titi Chen et al. KIDNEY INTERNATIONAL
- Complement component C5a induces aberrant epigenetic modifications in renal tubular epithelial cells accelerating senescence by Wnt4/βcatenin signaling after ischemia/reperfusion injury
- (2019) Giuseppe Castellano et al. Aging-US
- Use of Cell Cycle Arrest Biomarkers in Conjunction With Classical Markers of Acute Kidney Injury
- (2019) Michael Joannidis et al. CRITICAL CARE MEDICINE
- Targeting mTOR for cancer therapy
- (2019) Hui Hua et al. Journal of Hematology & Oncology
- Characterization of a novel anti-human lymphocyte activation gene 3 (LAG-3) antibody for cancer immunotherapy
- (2019) Xiaojie Yu et al. mAbs
- Urine macrophages reflect kidney macrophage content during acute tubular interstitial and glomerular injury
- (2019) Ping-ping Sun et al. CLINICAL IMMUNOLOGY
- Immune checkpoint inhibitor nephrotoxicity: what do we know and what should we do?
- (2019) Mark A. Perazella et al. KIDNEY INTERNATIONAL
- Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer
- (2019) Matthew D. Hellmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Poor Outcomes with the Use of Checkpoint Inhibitors in Kidney Transplant Recipients.
- (2019) Karthik Venkatachalam et al. TRANSPLANTATION
- The Incidence, Causes, and Risk Factors of Acute Kidney Injury in Patients Receiving Immune Checkpoint Inhibitors
- (2019) Harish Seethapathy et al. Clinical Journal of the American Society of Nephrology
- Lactate up-regulates the expression of PD-L1 in kidney and causes immunosuppression in septic Acute Renal Injury
- (2019) Jingjing Xu et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4
- (2019) Shuang Qin et al. Molecular Cancer
- Targeting the mTOR pathway uncouples the efficacy and toxicity of PD-1 blockade in renal transplantation
- (2019) Khashayar Esfahani et al. Nature Communications
- Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors
- (2019) Satya Das et al. Journal for ImmunoTherapy of Cancer
- The Role of Biomarkers in Acute Kidney Injury
- (2019) Nattachai Srisawat et al. CRITICAL CARE CLINICS
- Th17 cells contribute to pulmonary fibrosis and inflammation during chronic kidney disease progression after acute ischemia
- (2018) Purvi Mehrotra et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Improving Clinical Prediction Rules In Acute Kidney Injury With The Use of Biomarkers of Cell Cycle Arrest: A Pilot Study.
- (2018) Luke E Hodgson et al. BIOMARKERS
- Mechanisms of resistance to immune checkpoint inhibitors
- (2018) Russell W Jenkins et al. BRITISH JOURNAL OF CANCER
- Sirolimus for Secondary Prevention of Skin Cancer in Kidney Transplant Recipients: 5-Year Results
- (2018) Jacques Dantal et al. JOURNAL OF CLINICAL ONCOLOGY
- Gut microbiome modulates efficacy of immune checkpoint inhibitors
- (2018) Ming Yi et al. Journal of Hematology & Oncology
- Cytokine Release Syndrome During Sequential Treatment With Immune Checkpoint Inhibitors and Kinase Inhibitors for Metastatic Melanoma
- (2018) Florentia Dimitriou et al. JOURNAL OF IMMUNOTHERAPY
- Nephrotoxicity of Cancer Immunotherapies: Past, Present and Future
- (2018) Mark A. Perazella et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Sex and interleukin-6 are prognostic factors for autoimmune toxicity following treatment with anti-CTLA4 blockade
- (2018) Sara Valpione et al. Journal of Translational Medicine
- Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis
- (2018) Fabio Conforti et al. LANCET ONCOLOGY
- Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis
- (2018) Jennifer L McQuade et al. LANCET ONCOLOGY
- The use of cell cycle arrest biomarkers in the early detection of acute kidney injury. Is this the new renal troponin?
- (2018) Luis M. Ortega et al. NEFROLOGIA
- Programmed cell death protein 1 inhibitor treatment is associated with acute kidney injury and hypocalcemia: meta-analysis
- (2018) Sandhya Manohar et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
- (2018) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
- (2018) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients
- (2018) Vyara Matson et al. SCIENCE
- Immune checkpoint inhibitor (nivolumab)-associated kidney injury and the importance of recognizing concomitant medications known to cause acute tubulointerstitial nephritis: a case report
- (2018) Ryo Koda et al. BMC Nephrology
- Serum levels of soluble CD163 and CXCL5 may be predictive markers for immune-related adverse events in patients with advanced melanoma treated with nivolumab: a pilot study
- (2018) Taku Fujimura et al. Oncotarget
- Tumor PD-L1 Expression and Clinical Outcomes in Advanced-stage Non-Small Cell Lung Cancer Patients Treated with Nivolumab or Pembrolizumab: Real-World Data in Taiwan
- (2018) Shu-Yung Lin et al. Journal of Cancer
- Reversing the immune ageing clock: lifestyle modifications and pharmacological interventions
- (2018) Niharika A. Duggal BIOGERONTOLOGY
- Optimal oncologic management and mTOR inhibitor introduction are safe and improve survival in kidney and liver allograft recipients with de novo carcinoma
- (2018) B. Rousseau et al. INTERNATIONAL JOURNAL OF CANCER
- Senescence markers - predictive for response to checkpoint inhibitors?
- (2018) Alvaro Moreira et al. INTERNATIONAL JOURNAL OF CANCER
- The Human Gut Microbiome – A Potential Controller of Wellness and Disease
- (2018) Zhi Y. Kho et al. Frontiers in Microbiology
- Prognostic Factors for Checkpoint Inhibitor Based Immunotherapy: An Update With New Evidences
- (2018) Xinyu Yan et al. Frontiers in Pharmacology
- Risk of lung cancer in lung transplant recipients in the United States
- (2018) Matthew Triplette et al. AMERICAN JOURNAL OF TRANSPLANTATION
- The impact of immunosenescence on the efficacy of immune checkpoint inhibitors in melanoma patients: a meta-analysis
- (2018) Ping Li et al. OncoTargets and Therapy
- A possible interaction between periostin and CD163+ skin-resident macrophages in pemphigus vulgaris and bullous pemphigoid
- (2017) Taku Fujimura et al. EXPERIMENTAL DERMATOLOGY
- Successful treatment of metastatic clear cell carcinoma with nivolumab in a patient receiving dialysis treatment
- (2017) Tadashi Tabei et al. INTERNATIONAL JOURNAL OF UROLOGY
- Serum level of interleukin-6 is increased in nivolumab-associated psoriasiform dermatitis and tumor necrosis factor-α is a biomarker of nivolumab recativity
- (2017) Ryota Tanaka et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Nivolumab-associated Nephrotic Syndrome in a Patient With Renal Cell Carcinoma
- (2017) Robin A. Daanen et al. JOURNAL OF IMMUNOTHERAPY
- Manipulating the gut microbiome to decrease uremic toxins
- (2017) Rabi Yacoub et al. KIDNEY INTERNATIONAL
- Evaluation of the impact of gut microbiota on uremic solute accumulation by a CE-TOFMS–based metabolomics approach
- (2017) Eikan Mishima et al. KIDNEY INTERNATIONAL
- Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup
- (2017) Lakhmir S. Chawla et al. Nature Reviews Nephrology
- Cancer Immunotherapy Trials Not Immune from Imprecise Selection of Patients
- (2017) Edward B. Garon NEW ENGLAND JOURNAL OF MEDICINE
- Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
- (2017) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preserved Renal-Allograft Function and the PD-1 Pathway Inhibitor Nivolumab
- (2017) Richard Barnett et al. NEW ENGLAND JOURNAL OF MEDICINE
- First-Line Nivolumab in Stage IV or Recurrent Non–Small-Cell Lung Cancer
- (2017) David P. Carbone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients
- (2017) V. Gopalakrishnan et al. SCIENCE
- Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
- (2017) Bertrand Routy et al. SCIENCE
- Interleukin-6, A Cytokine Critical to Mediation of Inflammation, Autoimmunity and Allograft Rejection
- (2017) Stanley C. Jordan et al. TRANSPLANTATION
- Severe Allograft Rejection and Autoimmune Hemolytic Anemia After Anti-PD1 Therapy in a Kidney Transplanted Patient
- (2017) Clément Deltombe et al. TRANSPLANTATION
- Relationships between lymphocyte counts and treatment-related toxicities and clinical responses in patients with solid tumors treated with PD-1 checkpoint inhibitors
- (2017) Adam Diehl et al. Oncotarget
- Comprehensive Meta-analysis of Key Immune-Related Adverse Events from CTLA-4 and PD-1/PD-L1 Inhibitors in Cancer Patients
- (2017) Guillermo De Velasco et al. Cancer Immunology Research
- Intergenerational transfer of antibiotic-perturbed microbiota enhances colitis in susceptible mice
- (2017) Anjelique F. Schulfer et al. Nature Microbiology
- Interstitial nephritis in melanoma patients secondary to PD-1 checkpoint inhibitor
- (2017) Julia Escandon et al. Journal for ImmunoTherapy of Cancer
- Association of Acute Interstitial Nephritis With Programmed Cell Death 1 Inhibitor Therapy in Lung Cancer Patients
- (2016) Anushree C. Shirali et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Lung–Kidney Cross-Talk in the Critically Ill Patient
- (2016) Faeq Husain-Syed et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Use of the PD-1 Pathway Inhibitor Nivolumab in a Renal Transplant Patient With Malignancy
- (2016) C. L. Boils et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Checkpoint Inhibitors in Kidney Transplant Recipients and the Potential Risk of Rejection
- (2016) T. Alhamad et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Serum lactate dehydrogenase as an early marker for outcome in patients treated with anti-PD-1 therapy in metastatic melanoma
- (2016) S Diem et al. BRITISH JOURNAL OF CANCER
- Acute interstitial nephritis related to immune checkpoint inhibitors
- (2016) Julie Belliere et al. BRITISH JOURNAL OF CANCER
- Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
- (2016) Willy Hugo et al. CELL
- Impact of acute kidney injury defined by CTCAE v4.0 during first course of cisplatin-based chemotherapy on treatment outcomes in advanced urothelial cancer patients
- (2016) Ryutaro Ishitsuka et al. Clinical and Experimental Nephrology
- Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab
- (2016) Benjamin Weide et al. CLINICAL CANCER RESEARCH
- Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab
- (2016) A. Martens et al. CLINICAL CANCER RESEARCH
- Drug-induced nephropathies
- (2016) Paisit Paueksakon et al. HISTOPATHOLOGY
- Systemic over-release of interleukin-17 in acute kidney injury after septic shock: Clinical and experimental evidence
- (2016) Panagiota Maravitsa et al. IMMUNOLOGY LETTERS
- Depletion of Gut Microbiota Protects against Renal Ischemia-Reperfusion Injury
- (2016) Diba Emal et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- mTOR inhibitors effects on regulatory T cells and on dendritic cells
- (2016) Giovanni Stallone et al. Journal of Translational Medicine
- Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors
- (2016) Frank B. Cortazar et al. KIDNEY INTERNATIONAL
- Ipilimumab-associated minimal-change disease
- (2016) Jason M. Kidd et al. KIDNEY INTERNATIONAL
- Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
- (2016) Roy S Herbst et al. LANCET
- Discovery of urinary metabolomic biomarkers for early detection of acute kidney injury
- (2016) A Jin Won et al. Molecular BioSystems
- Fulminant Myocarditis with Combination Immune Checkpoint Blockade
- (2016) Douglas B. Johnson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
- (2016) Martin Reck et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
- (2016) Jesse M. Zaretsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prognostic Value of Serum Lactate Dehydrogenase in Renal Cell Carcinoma: A Systematic Review and Meta-Analysis
- (2016) Jie Shen et al. PLoS One
- Pathological -synuclein transmission initiated by binding lymphocyte-activation gene 3
- (2016) X. Mao et al. SCIENCE
- Mixed acute kidney allograft rejection after an antiprogrammed cell death protein 1 antibody treatment for lung epidermoid carcinoma
- (2016) Mathilde Tamain et al. TRANSPLANT INTERNATIONAL
- Re-examining the Nature and Function of Self-Reactive T cells
- (2016) David M. Richards et al. TRENDS IN IMMUNOLOGY
- Nivolumab-associated acute glomerulonephritis: a case report and literature review
- (2016) Kyungsuk Jung et al. BMC Nephrology
- The Obesity Paradox in Cancer: a Review
- (2016) Hannah Lennon et al. Current Oncology Reports
- Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis
- (2016) Krista Dubin et al. Nature Communications
- Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints
- (2016) Shohei Koyama et al. Nature Communications
- Compensatory upregulation of PD-1, LAG-3, and CTLA-4 limits the efficacy of single-agent checkpoint blockade in metastatic ovarian cancer
- (2016) Ruea-Yea Huang et al. OncoImmunology
- Antitumor activity of nivolumab on hemodialysis after renal allograft rejection
- (2016) Michael Ong et al. Journal for ImmunoTherapy of Cancer
- Adverse Events Associated with Immune Checkpoint Blockade in Patients with Cancer: A Systematic Review of Case Reports
- (2016) Noha Abdel-Wahab et al. PLoS One
- Complement Modulation of Anti-Aging Factor Klotho in Ischemia/Reperfusion Injury and Delayed Graft Function
- (2015) G. Castellano et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper
- (2015) S. Champiat et al. ANNALS OF ONCOLOGY
- Oscillatory mTOR inhibition and Tregincrease in kidney transplantation
- (2015) M. Sabbatini et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Cancer immunotherapy: harnessing the immune system to battle cancer
- (2015) Yiping Yang JOURNAL OF CLINICAL INVESTIGATION
- Plasma IL-6 and IL-10 Concentrations Predict AKI and Long-Term Mortality in Adults after Cardiac Surgery
- (2015) W. R. Zhang et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Gut Bacteria Products Prevent AKI Induced by Ischemia-Reperfusion
- (2015) V. Andrade-Oliveira et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Soluble Serum αKlotho Is a Potential Predictive Marker of Disease Progression in Clear Cell Renal Cell Carcinoma
- (2015) Margherita Gigante et al. MEDICINE
- Galectin-3 Shapes Antitumor Immune Responses by Suppressing CD8+ T Cells via LAG-3 and Inhibiting Expansion of Plasmacytoid Dendritic Cells
- (2015) T. Kouo et al. Cancer Immunology Research
- Baseline circulating IL-17 predicts toxicity while TGF-β1 and IL-10 are prognostic of relapse in ipilimumab neoadjuvant therapy of melanoma
- (2015) Ahmad A. Tarhini et al. Journal for ImmunoTherapy of Cancer
- A Systematic Review of Conversion From Calcineurin Inhibitor to Mammalian Target of Rapamycin Inhibitors for Maintenance Immunosuppression in Kidney Transplant Recipients
- (2014) W. H. Lim et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Lactate dehydrogenase as a selection criterion for ipilimumab treatment in metastatic melanoma
- (2014) Sander Kelderman et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Kidney injuries related to ipilimumab
- (2014) Hassane Izzedine et al. INVESTIGATIONAL NEW DRUGS
- Both PD-1 Ligands Protect the Kidney from Ischemia Reperfusion Injury
- (2014) Katarzyna Jaworska et al. JOURNAL OF IMMUNOLOGY
- A nationwide nested case-control study indicates an increased risk of acute interstitial nephritis with proton pump inhibitor use
- (2014) Mei-Ling Blank et al. KIDNEY INTERNATIONAL
- Intestinal Microbiota-Kidney Cross Talk in Acute Kidney Injury and Chronic Kidney Disease
- (2014) Sanjeev Noel et al. NEPHRON CLINICAL PRACTICE
- Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
- (2014) Alexandra Snyder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Co-Inhibitory Pathways and Their Importance in Immune Regulation
- (2014) Naoka Murakami et al. TRANSPLANTATION
- Erratum to: Clinical and pathological outcomes of renal cell carcinoma (RCC) in native kidneys of patients with end-stage renal disease: a long-term comparative retrospective study with RCC diagnosed in the general population
- (2014) Alberto Breda et al. WORLD JOURNAL OF UROLOGY
- Effect of sirolimus on malignancy and survival after kidney transplantation: systematic review and meta-analysis of individual patient data
- (2014) G. A. Knoll et al. BMJ-British Medical Journal
- Experience in daily practice with ipilimumab for the treatment of patients with metastatic melanoma: an early increase in lymphocyte and eosinophil counts is associated with improved survival
- (2013) J. Delyon et al. ANNALS OF ONCOLOGY
- Patterns of onset and resolution of immune-related adverse events of special interest with ipilimumab
- (2013) Jeffrey S. Weber et al. CANCER
- At the Bench: Preclinical rationale for CTLA-4 and PD-1 blockade as cancer immunotherapy
- (2013) Andrew M. Intlekofer et al. JOURNAL OF LEUKOCYTE BIOLOGY
- T-helper-1-cell cytokines drive cancer into senescence
- (2013) Heidi Braumüller et al. NATURE
- Understanding immunosenescence to improve responses to vaccines
- (2013) Jörg J Goronzy et al. NATURE IMMUNOLOGY
- Nivolumab plus Ipilimumab in Advanced Melanoma
- (2013) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Management of Immune-Related Adverse Events and Kinetics of Response With Ipilimumab
- (2012) Jeffrey S. Weber et al. JOURNAL OF CLINICAL ONCOLOGY
- Autocrine Adenosine Signaling Promotes Regulatory T Cell-Mediated Renal Protection
- (2012) G. R. Kinsey et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Sirolimus and Secondary Skin-Cancer Prevention in Kidney Transplantation
- (2012) Sylvie Euvrard et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diagnostic value of urine sCD163 levels for sepsis and relevant acute kidney injury: a prospective study
- (2012) Longxiang Su et al. BMC Nephrology
- Hallmarks of human “immunosenescence”: adaptation or dysregulation?
- (2012) Graham Pawelec Immunity & Ageing
- Spectrum of Cancer Risk Among US Solid Organ Transplant Recipients
- (2011) Eric A. Engels et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Shifting the balance: antibiotic effects on host–microbiota mutualism
- (2011) Benjamin P. Willing et al. NATURE REVIEWS MICROBIOLOGY
- Role of Indoxyl Sulfate in the Progression of Chronic Kidney Disease and Cardiovascular Disease: Experimental and Clinical Effects of Oral Sorbent AST-120
- (2011) Toshimitsu Niwa THERAPEUTIC APHERESIS AND DIALYSIS
- Sirolimus and Proteinuria in Renal Transplant Patients: Evidence for a Dose-Dependent Effect on Slit Diaphragm-Associated Proteins
- (2011) Giovanni Stallone et al. TRANSPLANTATION
- An Oscillatory Switch in mTOR Kinase Activity Sets Regulatory T Cell Responsiveness
- (2010) Claudio Procaccini et al. IMMUNITY
- The PD-1 pathway in tolerance and autoimmunity
- (2010) Loise M. Francisco et al. IMMUNOLOGICAL REVIEWS
- Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen–specific CD8+T cell dysfunction in melanoma patients
- (2010) Julien Fourcade et al. JOURNAL OF EXPERIMENTAL MEDICINE
- T helper 1, 2 and 17 cell subsets in renal transplant patients with delayed graft function
- (2010) Antonia Loverre et al. TRANSPLANT INTERNATIONAL
- LDH correlation with survival in advanced melanoma from two large, randomised trials (Oblimersen GM301 and EORTC 18951)
- (2009) Sanjiv S. Agarwala et al. EUROPEAN JOURNAL OF CANCER
- Interleukin-23/Th17 pathways and inflammatory bowel disease
- (2009) Clara Abraham et al. INFLAMMATORY BOWEL DISEASES
- Interferon-alpha (IFN-α)–conditioned DC Preferentially Stimulate Type-1 and Limit Treg-type In Vitro T-cell Responses From RCC Patients
- (2009) Margherita Gigante et al. JOURNAL OF IMMUNOTHERAPY
- CTLA4 blockade increases Th17 cells in patients with metastatic melanoma
- (2009) Erika von Euw et al. Journal of Translational Medicine
- Anti-CTLA4 Antibody–Induced Lupus Nephritis
- (2009) Fouad Fadel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dysfunctional DC subsets in RCC patients: Ex vivo correction to yield an effective anti-cancer vaccine
- (2008) M. Gigante et al. MOLECULAR IMMUNOLOGY
- AST-120 Treatment in Pre-Dialysis Period Affects the Prognosis in Patients on Hemodialysis
- (2008) Haruhiko Ueda et al. RENAL FAILURE
- CTLA-4 Control over Foxp3+ Regulatory T Cell Function
- (2008) K. Wing et al. SCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search